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Characteristics associated with group sex participation among 
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Mance E. Buttram and Steven P. Kurtz
Center for Applied Research on Substance Use and Health Disparities, 2 NE 40th Street, Suite 
404, Miami, FL 33137, USA
Abstract
This study examined the demographics, substance use and sexual risk behaviours associated with 
group sex (GS) participation among a sample of club drug users (n = 498) in Miami. Men (n = 
128; 46.3%) and women (n = 75; 33.7%) reported histories of GS. Group sex participation among 
men and women was associated with heroin and injection drug use, trading or selling sex, and sex 
while high, compared with no GS participation. Moreover, among men, GS was associated with 
buying sex and sex with an injection drug user; among women, GS was associated with substance 
dependence, a history of sexually transmissible infections and crack cocaine use, compared with 
no GS participation.
Additional keywords
heterosexual; HIV; opioids; sexually transmissible infections
Group sex (GS), in which people have sex with more than one partner in a single sexual 
encounter, may be an important influence on a community’s HIV and sexually transmissible 
infection (STI) rates and often includes participants from multiple populations, including 
injection drug users, substance non users, men who have sex with men, and sex buyers or 
exchangers.1,2 Limited data indicate that members of these disparate populations attend the 
same GS events and engage in condomless sex, allowing for HIV and STI transmission 
across group boundaries.1,2 The present study examines the demographics and background, 
substance use and HIV transmission risk behaviours associated with GS among a sample of 
heterosexual young adult club drug scene participants in Miami, Florida.
Data are drawn from an ongoing behavioural substance use and sexual risk reduction 
intervention trial. All participants were between the ages of 18–39 years and met the same 
past 90-day eligibility criteria, which included: (1) heterosexual sex, (2) use of club drugs 
(i.e. cocaine, ecstasy, g hydroxybutyric acid (GHB), methamphetamine, ketamine and 
lysergic acid diethylamide (LSD)) three or more times and (3) nonprescribed use of 
prescription medications one or more times. Participants also reported regular attendance at 
large recognized local nightclubs.
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The baseline assessments were primarily comprised of the Global Appraisal of Individual 
Needs (ver. 5.4),3 which has several core sections (e.g. background, substance use and 
(Diagnostic and Statistical Manual of Mental Disorders, 4th edition) substance dependence, 
mental distress, sexual risk behaviours, STI history and abuse history), with each section 
containing questions on the recency of problems, breadth of symptoms and recent (past 90 
days) and past year prevalence in days or times. Lifetime GS participation was defined as 
having sex with two or more people at one time. Measures were dichotomised into 1 
indicating endorsement of a characteristic or behaviour, and 0 indicating no endorsement. 
Bivariate logistic regression models were constructed to predict GS participation among men 
(n = 276) and women (n = 222) on measures of demographics and background, substance 
use, and HIV and STI risk behaviour. All analyses were conducted using IBM SPSS 
Statistics ver. 21.4
The recent use of alcohol, marijuana, cocaine and ecstasy, and non-prescribed use of 
prescription medications were nearly universally endorsed regardless of gender and GS 
participation (data not shown). Table 1 shows that men and women GS participants were 
more likely to report a history of sexual abuse, severe mental distress in the past year, recent 
heroin use and injection drug use, trading or selling sex in the past year, and recent sex while 
high half the time or more, compared with non-participants. Additionally, male GS 
participants were more likely to report recent GHB use, buying sex in the past year and 
recent sex with an injection drug user. Female GS participants were more likely to report 
being White, a history of physical abuse, substance dependence in the past year, a history of 
STI (i.e. syphilis, gonorrhoea (Neisseria gonorrhoeae) and chlamydia (Chlamydia 
trachomatis)) and recent crack use, and were less likely to report being Hispanic and 
heterosexual compared with non-participants.
This study has documented prevalent GS participation among a sample of young adult club 
drug users in Miami. Widespread substance use and HIV transmission risk behaviours 
suggest that GS participants may be placing themselves at high risk for HIV, STI and 
hepatitis C virus infection. Public health concern is especially high, given the literature, 
which suggests GS events function as spaces where many high-risk behaviours occur across 
multiple populations.1 The frequency of heroin use and injection drug use reported among 
GS participants in this study is alarming, especially because of the growing epidemic of 
opioid addiction among young adults in the USA.5 Recent data indicate a trend of sexual 
risk behaviours, including GS, among non-medical prescription opioid misusers reporting 
drug injection, heroin use or both.6 Moreover, although it is not uncommon for young adult 
club drug scene participants to report health and social problems, such as a history of abuse, 
substance dependence and mental distress,7 the findings illustrate the vulnerabilities of this 
population generally and of GS participants in particular.
This study has some limitations worth noting. The ability to generalise the findings to other 
young adults is limited by the eligibility requirements and the high frequencies of reported 
risk behaviours, and health and social problems among both GS and non-GS participants. 
All data are based on self-report, potentially leading to under-reporting of socially 
undesirable behaviours.
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Given the limited literature on GS among heterosexual populations, these data provide 
evidence that young adult club drug scene participants may represent a sentinel population 
with regard to the emergence of HIV, STI and hepatitis C virus incidence resulting from GS 
participation. Future research will need to investigate the links between emerging substance 
use trends, such as heroin use and injection drug use, and sexual risk behaviours, including 
GS participation. Prevention and intervention efforts that target health and social problems, 
in addition to substance use and sexual risk behaviours, especially among women, are likely 
to have a greater impact.
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